Compare · AS vs SILO
AS vs SILO
Side-by-side comparison of Amer Sports Inc. (AS) and Silo Pharma Inc. (SILO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AS and SILO operate in Apparel (Consumer Discretionary), so they compete in similar markets.
- AS is the larger of the two at $18.89B, about 185.5x SILO ($101.8M).
- Over the past year, AS is down 10.0% and SILO is down 35.0% - AS leads by 25.0 points.
- AS has been more active in the news (11 items in the past 4 weeks vs 2 for SILO).
- AS has more recent analyst coverage (25 ratings vs 0 for SILO).
PerformanceAS-10.02%SILO-35.00%
2025-06-09+0.00%2026-06-08
- Company
- Amer Sports Inc.
- Silo Pharma Inc.
- Price
- $33.88-0.63%
- $6.25+5.57%
- Market cap
- $18.89B
- $101.8M
- 1M return
- -7.16%
- -2.37%
- 1Y return
- -10.02%
- -35.00%
- Industry
- Apparel
- Apparel
- Exchange
- NYSE
- NASDAQ
- IPO
- 2024
- News (4w)
- 11
- 2
- Recent ratings
- 25
- 0
Latest AS
- Chief Executive Officer Zheng Jie (James) exercised 500,000 units of Ordinary Shares at a strike of $7.68 and sold $17,210,450 worth of Ordinary Shares (500,000 units at $34.42) (SEC Form 4)
- Chief Strategy Officer Chen Wen-Chang (Victor) sold $465,764 worth of Ordinary Shares (13,075 units at $35.62), decreasing direct ownership by 8% to 149,821 units (SEC Form 4)
- CEO of Arc'teryx Equipment Haselden Stuart exercised 200,000 units of Ordinary Shares at a strike of $12.51 and sold $7,656,766 worth of Ordinary Shares (215,275 units at $35.57), closing all direct ownership in the company (SEC Form 4)
- SEC Form 144 filed by Amer Sports Inc.
- Chief Financial Officer Page Andrew E sold $3,867,726 worth of Ordinary Shares (105,230 units at $36.75) and exercised 97,485 units of Ordinary Shares at a strike of $14.19, decreasing direct ownership by 65% to 4,083 units (SEC Form 4)
- SEC Form 144 filed by Amer Sports Inc.
- SEC Form 6-K filed by Amer Sports Inc.
- Amer Sports Reports First Quarter 2026 Financial Results, Raises Full Year Revenue, Margin, and EPS Guidance
- SEC Form 4 filed by Director Yiu Kin Wah Stephen
- SEC Form 4 filed by Director Salzer Bruno
Latest SILO
- Silo Pharma Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Silo Pharma Inc. filed SEC Form 8-K: Other Events
- Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
- Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
- Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
- SEC Form 424B3 filed by Silo Pharma Inc.
- SEC Form EFFECT filed by Silo Pharma Inc.
- SEC Form 424B3 filed by Silo Pharma Inc.
- SEC Form POS AM filed by Silo Pharma Inc.
- SEC Form EFFECT filed by Silo Pharma Inc.